Salveen Richter
Stock Analyst at Goldman Sachs
(2.36)
# 2,424
Out of 4,784 analysts
202
Total ratings
41.23%
Success rate
-1.16%
Average return
Main Sectors:
Stocks Rated by Salveen Richter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ADPT Adaptive Biotechnologies | Upgrades: Buy | $8 → $9 | $8.22 | +9.49% | 10 | Mar 21, 2025 | |
| APLS Apellis Pharmaceuticals | Maintains: Neutral | $36 → $32 | $24.28 | +31.80% | 8 | Mar 3, 2025 | |
| SMMT Summit Therapeutics | Initiates: Buy | $42 | $20.60 | +103.88% | 1 | Feb 28, 2025 | |
| RLAY Relay Therapeutics | Maintains: Buy | $20 → $18 | $2.99 | +502.01% | 3 | Feb 27, 2025 | |
| CRSP CRISPR Therapeutics AG | Maintains: Neutral | $66 → $57 | $38.04 | +49.84% | 3 | Feb 13, 2025 | |
| BIIB Biogen | Maintains: Buy | $281 → $245 | $140.33 | +74.59% | 3 | Feb 13, 2025 | |
| GILD Gilead Sciences | Maintains: Neutral | $85 → $96 | $111.16 | -13.64% | 5 | Feb 12, 2025 | |
| MRNA Moderna | Downgrades: Neutral | $99 → $51 | $32.12 | +58.78% | 10 | Jan 29, 2025 | |
| DNLI Denali Therapeutics | Maintains: Buy | $45 → $40 | $14.20 | +181.69% | 5 | Jan 28, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Neutral | $20 → $12 | $8.40 | +42.86% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $20 | $13.13 | +52.38% | 7 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $63 → $70 | $60.68 | +15.36% | 9 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $198 → $370 | $271.02 | +36.52% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $67 → $76 | $38.89 | +95.42% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $33 → $37 | $31.72 | +16.65% | 3 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $11 | $8.66 | +27.02% | 11 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $33 → $53 | $30.84 | +71.85% | 9 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $313 → $350 | $305.77 | +14.47% | 7 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $81 | $3.56 | +2,175.28% | 3 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $442 → $559 | $502.55 | +11.23% | 4 | Jan 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $5 | $4.95 | +1.01% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4.5 → $5 | $14.51 | -65.54% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $188 → $215 | $71.81 | +199.40% | 3 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $8.59 | +28.06% | 1 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $31 | $1.56 | +1,887.18% | 7 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $257 → $225 | $269.81 | -16.61% | 1 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $22 | $2.00 | +1,000.00% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.59 | - | 4 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $4.54 | +560.79% | 5 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $14 | $0.82 | +1,596.97% | 3 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8 → $9 | $5.97 | +50.75% | 6 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $16 → $3 | $1.88 | +59.57% | 4 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $15 → $12 | $17.19 | -30.19% | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $1.85 | +225.20% | 3 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $39 → $43 | $51.26 | -16.11% | 1 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $796 → $970 | $635.83 | +52.56% | 9 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $40 → $60 | $3.79 | +1,483.11% | 6 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $3 → $2 | $1.30 | +53.85% | 3 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $125 → $100 | $6.88 | +1,353.49% | 1 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $28 | $8.49 | +229.99% | 2 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 → $30 | $0.41 | +7,160.41% | 3 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $57 → $50 | $98.19 | -49.08% | 4 | Mar 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $13.80 | +226.09% | 1 | Mar 17, 2020 |
Adaptive Biotechnologies
Mar 21, 2025
Upgrades: Buy
Price Target: $8 → $9
Current: $8.22
Upside: +9.49%
Apellis Pharmaceuticals
Mar 3, 2025
Maintains: Neutral
Price Target: $36 → $32
Current: $24.28
Upside: +31.80%
Summit Therapeutics
Feb 28, 2025
Initiates: Buy
Price Target: $42
Current: $20.60
Upside: +103.88%
Relay Therapeutics
Feb 27, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $2.99
Upside: +502.01%
CRISPR Therapeutics AG
Feb 13, 2025
Maintains: Neutral
Price Target: $66 → $57
Current: $38.04
Upside: +49.84%
Biogen
Feb 13, 2025
Maintains: Buy
Price Target: $281 → $245
Current: $140.33
Upside: +74.59%
Gilead Sciences
Feb 12, 2025
Maintains: Neutral
Price Target: $85 → $96
Current: $111.16
Upside: -13.64%
Moderna
Jan 29, 2025
Downgrades: Neutral
Price Target: $99 → $51
Current: $32.12
Upside: +58.78%
Denali Therapeutics
Jan 28, 2025
Maintains: Buy
Price Target: $45 → $40
Current: $14.20
Upside: +181.69%
Intellia Therapeutics
Jan 14, 2025
Maintains: Neutral
Price Target: $20 → $12
Current: $8.40
Upside: +42.86%
Dec 12, 2024
Maintains: Neutral
Price Target: $9 → $20
Current: $13.13
Upside: +52.38%
Oct 30, 2024
Maintains: Neutral
Price Target: $63 → $70
Current: $60.68
Upside: +15.36%
Aug 16, 2024
Upgrades: Buy
Price Target: $198 → $370
Current: $271.02
Upside: +36.52%
Aug 2, 2024
Maintains: Buy
Price Target: $67 → $76
Current: $38.89
Upside: +95.42%
Aug 2, 2024
Maintains: Sell
Price Target: $33 → $37
Current: $31.72
Upside: +16.65%
Jul 26, 2024
Maintains: Neutral
Price Target: $19 → $11
Current: $8.66
Upside: +27.02%
Jun 4, 2024
Maintains: Neutral
Price Target: $33 → $53
Current: $30.84
Upside: +71.85%
Feb 8, 2024
Maintains: Buy
Price Target: $313 → $350
Current: $305.77
Upside: +14.47%
Feb 7, 2024
Reinstates: Buy
Price Target: $81
Current: $3.56
Upside: +2,175.28%
Jan 31, 2024
Maintains: Buy
Price Target: $442 → $559
Current: $502.55
Upside: +11.23%
Sep 13, 2023
Downgrades: Neutral
Price Target: $5
Current: $4.95
Upside: +1.01%
Aug 15, 2023
Maintains: Neutral
Price Target: $4.5 → $5
Current: $14.51
Upside: -65.54%
Jun 23, 2023
Maintains: Buy
Price Target: $188 → $215
Current: $71.81
Upside: +199.40%
Mar 2, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $8.59
Upside: +28.06%
Mar 2, 2023
Maintains: Buy
Price Target: $35 → $31
Current: $1.56
Upside: +1,887.18%
Feb 24, 2023
Maintains: Overweight
Price Target: $257 → $225
Current: $269.81
Upside: -16.61%
Nov 14, 2022
Initiates: Neutral
Price Target: $22
Current: $2.00
Upside: +1,000.00%
Nov 11, 2022
Downgrades: Neutral
Price Target: n/a
Current: $0.59
Upside: -
Nov 10, 2022
Maintains: Neutral
Price Target: $60 → $30
Current: $4.54
Upside: +560.79%
Nov 10, 2022
Maintains: Buy
Price Target: $25 → $14
Current: $0.82
Upside: +1,596.97%
Nov 9, 2022
Maintains: Neutral
Price Target: $8 → $9
Current: $5.97
Upside: +50.75%
Nov 9, 2022
Downgrades: Neutral
Price Target: $16 → $3
Current: $1.88
Upside: +59.57%
Nov 4, 2022
Downgrades: Sell
Price Target: $15 → $12
Current: $17.19
Upside: -30.19%
Nov 3, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $1.85
Upside: +225.20%
Oct 28, 2022
Maintains: Neutral
Price Target: $39 → $43
Current: $51.26
Upside: -16.11%
Oct 3, 2022
Maintains: Buy
Price Target: $796 → $970
Current: $635.83
Upside: +52.56%
Aug 19, 2022
Maintains: Sell
Price Target: $40 → $60
Current: $3.79
Upside: +1,483.11%
May 24, 2022
Maintains: Sell
Price Target: $3 → $2
Current: $1.30
Upside: +53.85%
May 24, 2022
Maintains: Sell
Price Target: $125 → $100
Current: $6.88
Upside: +1,353.49%
May 12, 2022
Maintains: Neutral
Price Target: $48 → $28
Current: $8.49
Upside: +229.99%
Mar 4, 2021
Upgrades: Buy
Price Target: $28 → $30
Current: $0.41
Upside: +7,160.41%
Mar 19, 2020
Maintains: Neutral
Price Target: $57 → $50
Current: $98.19
Upside: -49.08%
Mar 17, 2020
Initiates: Neutral
Price Target: $45
Current: $13.80
Upside: +226.09%